Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Abbott Laboratories (ABT) had Revenue of $12.59B for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$12.59B
Net Income	$928.00M
Cost of Goods Sold	$5.33B
Gross Profit	$7.27B
Operating Expenses	$10.90B
Operating Income	$1.69B
Non-Operating Income/Expense	$-169.00M
Pre-Tax Income	$1.52B
Normalized Pre-Tax Income	$1.52B
Income after Taxes	$928.00M
Income from Continuous Operations	$928.00M
Consolidated Net Income/Loss	$928.00M
Normalized Income after Taxes	$928.00M
EBIT	$1.69B
EBITDA	$2.75B
Weighted-Average Shares Outstanding (Basic)	1.74B
Weighted-Average Shares Outstanding (Diluted)	1.74B
Earnings per Share (EPS) (Basic)	$0.53
Earnings per Share (EPS) (Diluted)	$0.53
Balance Sheet Financials
Current Assets	$24.52B
Property, Plant, and Equipment	$12.81B
Long-Term Assets	$84.70B
Total Assets	$109.22B
Current Liabilities	$17.81B
Long-Term Debt	$29.60B
Long-Term Liabilities	$39.64B
Total Liabilities	$57.45B
Common Equity	$51.76B
Tangible Shareholders Equity	$-693.00M
Shareholders Equity	$51.76B
Common Shares Outstanding	1.73B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.80B
Cash Flow from Investing Activities	$-21.00B
Cash Flow from Financial Activities	$13.79B
Beginning Cash	$8.52B
End Cash	$5.10B
Increase/Decrease in Cash	$-3.42B
Stock-Based Compensation	$485.00M
Common Stock Dividends Paid	$-2.20B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.38
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.63
Gross Margin	57.71%
Operating Margin	13.44%
EBIT Margin	13.44%
EBITDA Margin	--
Pre-Tax Profit Margin	12.10%
Profit Margin	7.37%
Free Cash Flow	$2.91B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.73
Receiveable Turnover	1.46
Days Sales in Receivables	61.46
Return on Equity	1.79%
Return on Tangible Equity	-133.91%
Return on Assets	0.85%
Return on Investments	1.14%
Book Value Per Share	$29.91
Free Cash Flow per Share	$1.67
Operating Cash Flow per Share	$2.18

Data from Zacks Investment Research, Inc.